-+ 0.00%
-+ 0.00%
-+ 0.00%

Ocular Therapeutix Grants 200,000 Stock Options, 65,000 RSUs to New Executive Tiffany Howard

PUBT·11/20/2026 12:00:50
Listen to the news
Ocular Therapeutix Grants 200,000 Stock Options, 65,000 RSUs to New Executive Tiffany Howard
  • Ocular Therapeutix granted equity awards to Tiffany Howard, its new executive vice president, commercial - retina.
  • Effective November 16, 2026, awards comprise non-statutory stock options for up to 200,000 common shares and restricted stock units covering 65,000 common shares.
  • The options have a 10-year term, with 25% vesting on the grant’s first anniversary.
  • Remaining options vest in equal monthly installments over the following three years, bringing total vesting to four years.
  • Restricted stock units vest in equal annual installments over three years; both awards require continued service through applicable vesting dates.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611200700PRIMZONEFULLFEED9881894) on November 20, 2026, and is solely responsible for the information contained therein.